Latest News

No evidence related to transferability of biomarker tests for decision-making on chemotherapy for breast cancer

Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.

Source link

Related posts

STAT Plus: HHS advances proposal that could require prices be included in drug ads


Is It Safe To Drink Coffee When You Are Sick?


SARS-CoV-2 genome variants in India


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World